Group One Trading
NDRM

Group One Trading’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Group One Trading’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,200
Closed -$124K – 5676
2017
Q3 		$124K Sell
3,200
-3,300
-51% -$121K ﹤0.01% 3096
2017
Q2 		$194K Sell
6,500
-38,000
-85% -$984K ﹤0.01% 2669
2017
Q1 		$1.18M Buy
44,500
+3,800
+9% +$94.1K 0.01% 1223
2016
Q4 		$904K Buy
40,700
+31,400
+338% +$587K 0.01% 1372
2016
Q3 		$172K Hold
9,300
– – ﹤0.01% 2576
2016
Q2 		$151K Sell
9,300
-15,700
-63% -$264K ﹤0.01% 2599
2016
Q1 		$353K Buy
25,000
+19,500
+355% +$263K 0.01% 1950
2015
Q4 		$94K Buy
5,500
+5,000
+1,000% +$97.4K ﹤0.01% 3011
2015
Q3 		$10K Buy
+500
New +$10.3K ﹤0.01% 4322

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Group One Trading's NDRM Position: Q2 2017 in Review

Group One Trading sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q2 2017, closing a stake of 41,083 shares — an estimated $1.06M sold.

Group One Trading first reported a position in NDRM in Q4 2015 and held it in 6 quarters. The position peaked at $1.09M in Q1 2017. 73 funds tracked by Wall St. Rank hold NDRM as of Q2 2017.

  • Group One Trading reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q2 2017 after selling out during the quarter.
  • Group One Trading sold 41,083 NeuroDerm Ltd. Ordinary Shares shares in Q2 2017, an estimated $1.06M.
  • Group One Trading first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2015 and held it in 6 quarters.
  • Group One Trading's NeuroDerm Ltd. Ordinary Shares position peaked at $1.09M in Q1 2017.
  • 73 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q2 2017.

Based on Group One Trading's 13F filing for Q2 2017, filed 14 Aug 2017.